These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 412532)

  • 1. An unusual case of a plasma cell neoplasm with an IgG3lambda myeloma and a gamma3 heavy chain disease protein.
    Adlersberg JB; Grann V; Zucker-Franklin D; Frangione B; Franklin EC
    Blood; 1978 Jan; 51(1):85-96. PubMed ID: 412532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgD myeloma or delta heavy-chain disease?
    Vladutiu AO
    Clin Chem; 1980 Feb; 26(2):353-4. PubMed ID: 6766363
    [No Abstract]   [Full Text] [Related]  

  • 3. 'Incomplete' pyroglobulin-gamma disease in a patient with osteosclerotic myeloma.
    Ruiz-Arguelles A; Valls-de-Ruiz M; Dominguez-Barranco A; Ruiz-Arguelles G; Ruiz-Reyes G
    Scand J Haematol; 1984 Oct; 33(4):351-5. PubMed ID: 6438794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A window into immunoglobulin quantitation and plasma cell disease: antigen epitopes defined by the junction of immunoglobulin heavy and light chains.
    Katzmann JA; Rajkumar SV
    Leukemia; 2013 Jan; 27(1):1-2. PubMed ID: 23299499
    [No Abstract]   [Full Text] [Related]  

  • 5. Spontaneous enzymatic cleavage of IgD myeloma protein giving a pattern of delta heavy chain disease.
    Rabhi H; Ghaffor M; Abbadi MC
    Arch Inst Pasteur Alger; 1989; 57():135-40. PubMed ID: 2518742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual sequence of immunoglobulin L-chain rearrangements in a gamma heavy chain disease patient.
    Hauke G; Schiltz E; Bross KJ; Hollmann A; Peter HH; Krawinkel U
    Scand J Immunol; 1992 Sep; 36(3):463-8. PubMed ID: 1519038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heavy/light chain specific immunoglobulin ratios provides no additional information than serum proteins electrophoresis and immunofixation for the diagnosis and the follow-up of intact immunoglobulin multiple myeloma patients.
    Beaumont-Epinette MP; Moreau C; Besnard S; Latute F; Collet N; Sebillot M; Grosbois B; Bendavid C; Guenet L; Decaux O
    Pathol Biol (Paris); 2015 Sep; 63(4-5):215-21. PubMed ID: 26319969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gamma-1 heavy chain disease with the demonstration of Bence-Jones proteins].
    Hauke G; Krawinkel U; Schiltz E; Metz B; Hollmann A; Peter HH
    Immun Infekt; 1991 Jun; 19(3):89-90. PubMed ID: 1916871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of immunoglobulin heavy and light chains in the absence of the VH domain.
    Levo Y; Recht B; Michaelsen T; Franklin EC; Frangione B
    J Immunol; 1977 Aug; 119(2):635-40. PubMed ID: 407302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Articular, monoclonal gamma3 heavy-chain deposition disease: characterization of a partially deleted heavy-chain gene and its protein product synthesized in vivo and in vitro.
    Thompson KM; Sletten K; Brandtzaeg P; Källberg E; Wien TN; Husby G
    Arthritis Rheum; 2003 Nov; 48(11):3266-71. PubMed ID: 14613292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgD myeloma protein with "unreactive" light chain determinants.
    Cejka J; Kithier K
    Clin Chem; 1979 Aug; 25(8):1495-8. PubMed ID: 88283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
    Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
    Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgD-lambda myeloma with separate heavy- and light-chain M-components.
    Vilpo JA; Irjala K
    Clin Chem; 1980 Nov; 26(12):1760-1. PubMed ID: 6775847
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthetic peptides VH(27-68) and VH(16-68) of the myeloma immunoglobulin M603 heavy chain and their association with the natural light chain to form an antigen binding site.
    Kubiak T; Whitney DB; Merrifield RB
    Biochemistry; 1987 Dec; 26(24):7849-55. PubMed ID: 3122833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of preferential reassociation between heavy and light chains of two human immunoglobulins from common cellular origin.
    de Preval C; Fougereau M
    Biochem Biophys Res Commun; 1975 Nov; 67(1):236-9. PubMed ID: 812494
    [No Abstract]   [Full Text] [Related]  

  • 16. Human heavy chain disease protein WIS: implications for the organization of immunoglobulin genes.
    Franklin EC; Prelli F; Frangione B
    Proc Natl Acad Sci U S A; 1979 Jan; 76(1):452-6. PubMed ID: 106391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new case of gamma-3 heavy chain disease. Biochemical and immunological investigations.
    Biewenga J; van Loghem E
    Vox Sang; 1979; 36(4):193-8. PubMed ID: 88813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin heavy and light chain isotypes in multiple myeloma patients.
    Ansari NA; Owais M; Usha
    Asian Pac J Cancer Prev; 2007; 8(4):593-6. PubMed ID: 18260735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretation Difficulties of Serum Immunofixation Test in Immunoglobulin D Multiple Myeloma with Hidden Lambda Light Chains.
    Biaz A; Uwingabiye J; Rachid A; Dami A; Bouhsain S; Ouzzif Z; Idrissi SEM
    Clin Lab; 2018 Jun; 64(6):1065-1069. PubMed ID: 29945318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-dimensional gel electrophoresis as an aid in the analysis of monoclonal gammopathies.
    Tracy RP; Kyle RA; Young DS
    Hum Pathol; 1984 Feb; 15(2):122-9. PubMed ID: 6421714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.